Dr. Alan So, MD, FRCSC, Uro-Oncologist, talks about the different treatment options for prostate cancer. Canada’s win over ...

Accurate calculation of prostate-specific antigen doubling time can be crucial for prostate cancer treatment decisions but is ...

[8] These study participants may be end-stage prostatitis patients who failed treatment with the study drugs, which are commonly prescribed in the community setting. Men with less severe symptoms ...

There are differences in prostate cancer treatment intensification adoption between academic and nonacademic physicians.

Sky News was granted access to a pilot study in Ireland which aims to save thousands of lives - amid fears many men in the UK ...

Combining an existing small-molecule protein therapy called tumor necrosis factor related apoptosis-inducing ligand (TRAIL) ...

especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting ... Study Finds New Blood Test Predicts Prognosis for Advanced ...

A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted treatments with fewer “awful” side effects.

According to ZERO Prostate Cancer, Novartis has committed $7.5 million to the initiative.

A new study gives hope for improved treatment of prostate cancer, the second most diagnosed cancer among men worldwide.

About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet ...